Agency Information Collection Request; 30-Day Public Comment Request, 44891-44892 [2018-19084]
Download as PDF
44891
Federal Register / Vol. 83, No. 171 / Tuesday, September 4, 2018 / Notices
consumption, with the exception of
dietary supplements, medical foods, and
foods for special dietary use. This notice
applies to foods such as produce, grains,
processed foods, food additives, color
additives, food contact substances,
generally regarded as safe ingredients,
infant formula, and all other foods not
specifically excluded. Dietary
supplements, medical foods, and foods
for special dietary use are excluded
from this notice.
II. Fees To Be Assessed for Export
Certificates
CFSAN estimates the annual costs of
the export certification program for food
for human consumption, with the
exception of dietary supplements,
medical foods, and foods for special
dietary use, to be approximately
$975,000 per year for preparing and
issuing export certificates. The costs are
due to payroll and operating expenses.
Specifically, there are four cost
categories for preparing and issuing
export certificates in general: (1) Direct
personnel for research, review, tracking,
writing, and assembly; (2) an
information technology system used for
tracking and processing certificates; (3)
billing and collection of fees; and (4)
overhead and administrative support. In
fiscal year (FY) 2017 CFSAN issued
approximately 4,072 export certificates
for food for human consumption, with
the exception of dietary supplements,
medical foods, and foods for special
dietary use. Because CFSAN has not
been charging fees for issuing these
export certificates, the program has been
covered by appropriated funds.
As mentioned previously, FDA may
charge up to $175 for each certificate.
Certificates for some of the foods that
are the subject of this notice cost us
more than $175 to prepare. Subsequent
certificates issued for the same
product(s) in response to the same
request generally cost FDA less than
$175 to prepare. The fee for all
subsequent certificates for the same
product(s) issued in response to the
same request reflects reduced FDA costs
for preparing those certificates.
The following fees will be assessed
starting October 1, 2018, for export
certificates for food for human
consumption, with the exception of
dietary supplements, medical foods, and
foods for special dietary use:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
SUMMARY:
TABLE 1—CFSAN FEES FOR FIRST,
SECOND, AND SUBSEQUENT EXPORT
CERTIFICATES
Fee
(dollars)
Type of certificate
First certificate ......................
Second certificate for the
same product(s) issued in
response to the same request .................................
Subsequent certificates for
the same product(s)
issued in response to the
same request ....................
Notice.
Comments on the ICR must be
received on or before October 4, 2018.
DATES:
175
Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
ADDRESSES:
155
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714. When submitting
100
comments or requesting information,
please include the document identifier
The fee for issuing the first export
4040–0014–30D and project title for
certificate for food for human
reference.
consumption, with the exception of
dietary supplements, medical foods, and
SUPPLEMENTARY INFORMATION: Interested
foods for special dietary use, will be at
persons are invited to send comments
the maximum allowable amount and
regarding this burden estimate or any
consistent with the export certification
other aspect of this collection of
fees assessed since FY 1997 by other
information, including any of the
FDA Centers that provide export
following subjects: (1) The necessity and
certification for drugs and devices. It is
utility of the proposed information
also consistent with the export
collection for the proper performance of
certification fees assessed by the Center
the agency’s functions; (2) the accuracy
for Veterinary Medicine (CVM) for
certificates for animal food, which CVM of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
began assessing in FY 2016 because the
FSMA amendments to section 801(e)(4)
of the information to be collected; and
of the FD&C Act also apply to animal
(4) the use of automated collection
food. The fees for issuing subsequent
techniques or other forms of information
certificates continue to differ among the technology to minimize the information
Centers, based on varying costs.
collection burden.
Dated: August 28, 2018.
Title of the Collections: Federal
Leslie Kux,
Financial Report (SF–425) and Federal
Associate Commissioner for Policy.
Financial Report Attachment (SF–
[FR Doc. 2018–19064 Filed 8–31–18; 8:45 am]
425A).
BILLING CODE 4164–01–P
Type of Collection: Extension.
OMB No.: 4040–0014.
DEPARTMENT OF HEALTH AND
Abstract: Federal Financial Report
HUMAN SERVICES
(SF–425) and Federal Financial Report
Attachment (SF–425A) are OMB[Document Identifier: OS–4040–0014]
approved collections (4040–0014).
Agency Information Collection
These information collections are used
Request; 30-Day Public Comment
by grant awardees. The ICs expire on
Request
January 31, 2019. We are requesting a
three-year clearance of these collections.
AGENCY: Office of the Secretary, HHS.
sradovich on DSK3GMQ082PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN TABLE
Average
burden hours
per response
Type of
respondent
Federal Financial Report (SF–425) ................................
Federal Financial Report Attachment (SF–425A) ...........
Grant Applicant ..
Grant Applicant ..
100,000
100,000
1
1
1
1
100,000
100,000
Total .........................................................................
............................
200,000
........................
........................
200,000
VerDate Sep<11>2014
17:54 Aug 31, 2018
Jkt 244001
PO 00000
Frm 00035
Fmt 4703
Number of
respondents
Number of
responses per
respondent
Forms
Sfmt 4703
E:\FR\FM\04SEN1.SGM
04SEN1
Total
burden hours
44892
Federal Register / Vol. 83, No. 171 / Tuesday, September 4, 2018 / Notices
Terry Clark,
Office of the Secretary, Asst. Paperwork
Reduction Act Reports Clearance Officer.
[FR Doc. 2018–19084 Filed 8–31–18; 8:45 am]
BILLING CODE 4151–AE–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–6: NCI
Clinical and Translational R21 & Omnibus
R03.
Date: October 4, 2018.
Time: 7:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Eduardo E. Chufan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Bethesda, MD 20892–
9750, 240–276–7975, chufanee@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–9: NCI
Clinical and Translational R21 and Omnibus
R03.
Date: October 23, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W114, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W114, Bethesda, MD 20892–
9750, 240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
I—Transition to Independence.
Date: October 24–25, 2018.
VerDate Sep<11>2014
17:54 Aug 31, 2018
Jkt 244001
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Delia Tang, MD, Scientific
Review Officer, Research Programs Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W602, Bethesda, MD
20892–9750, 240–276–6456, tangd@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–8: NCI
Clinical and Translational R21 and Omnibus
R03.
Date: November 1–2, 2018.
Time: 6:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W106, Bethesda, MD 20892–
9750, 240–276–6384, gravesr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; HIV/AIDS
and the Tumor Niche.
Date: November 13, 2018.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W618, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Mukesh Kumar, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W618,
Bethesda, MD 20892–9750, 240–276–6611,
mukesh.kumar3@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 28, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–19051 Filed 8–31–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of HHS-Certified
Laboratories and Instrumented Initial
Testing Facilities Which Meet Minimum
Standards To Engage in Urine Drug
Testing for Federal Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) notifies federal
agencies of the laboratories and
Instrumented Initial Testing Facilities
(IITF) currently certified to meet the
standards of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines).
A notice listing all currently HHScertified laboratories and IITFs is
published in the Federal Register
during the first week of each month. If
any laboratory or IITF certification is
suspended or revoked, the laboratory or
IITF will be omitted from subsequent
lists until such time as it is restored to
full certification under the Mandatory
Guidelines.
If any laboratory or IITF has
withdrawn from the HHS National
Laboratory Certification Program (NLCP)
during the past month, it will be listed
at the end and will be omitted from the
monthly listing thereafter.
This notice is also available on the
internet at https://www.samhsa.gov/
workplace.
FOR FURTHER INFORMATION CONTACT:
Charles LoDico, Division of Workplace
Programs, SAMHSA/CSAP, 5600
Fishers Lane, Room 16N02C, Rockville,
Maryland 20857; 240–276–2600 (voice).
SUPPLEMENTARY INFORMATION: The
Department of Health and Human
Services (HHS) notifies federal agencies
of the laboratories and Instrumented
Initial Testing Facilities (IITF) currently
certified to meet the standards of the
Mandatory Guidelines for Federal
Workplace Drug Testing Programs
(Mandatory Guidelines). The Mandatory
Guidelines were first published in the
Federal Register on April 11, 1988 (53
FR 11970), and subsequently revised in
the Federal Register on June 9, 1994 (59
FR 29908); September 30, 1997 (62 FR
51118); April 13, 2004 (69 FR 19644);
November 25, 2008 (73 FR 71858);
December 10, 2008 (73 FR 75122); April
30, 2010 (75 FR 22809); and on January
23, 2017 (82 FR 7920).
The Mandatory Guidelines were
initially developed in accordance with
SUMMARY:
E:\FR\FM\04SEN1.SGM
04SEN1
Agencies
[Federal Register Volume 83, Number 171 (Tuesday, September 4, 2018)]
[Notices]
[Pages 44891-44892]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-19084]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-4040-0014]
Agency Information Collection Request; 30-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before October 4,
2018.
ADDRESSES: Submit your comments to [email protected] or via
facsimile to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: Sherrette Funn, [email protected]
or (202) 795-7714. When submitting comments or requesting information,
please include the document identifier 4040-0014-30D and project title
for reference.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collections: Federal Financial Report (SF-425) and
Federal Financial Report Attachment (SF-425A).
Type of Collection: Extension.
OMB No.: 4040-0014.
Abstract: Federal Financial Report (SF-425) and Federal Financial
Report Attachment (SF-425A) are OMB-approved collections (4040-0014).
These information collections are used by grant awardees. The ICs
expire on January 31, 2019. We are requesting a three-year clearance of
these collections.
Estimated Annualized Burden Table
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Forms Type of respondent Number of responses per hours per Total burden
respondents respondent response hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Federal Financial Report (SF-425).............. Grant Applicant........................ 100,000 1 1 100,000
Federal Financial Report Attachment (SF-425A).. Grant Applicant........................ 100,000 1 1 100,000
---------------------------------------------------------------
Total...................................... ....................................... 200,000 .............. .............. 200,000
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 44892]]
Terry Clark,
Office of the Secretary, Asst. Paperwork Reduction Act Reports
Clearance Officer.
[FR Doc. 2018-19084 Filed 8-31-18; 8:45 am]
BILLING CODE 4151-AE-P